Transforming scientific data into clinical knowledge
UW Drug Interaction Solutions provides tools to navigate drug interaction findings to get you to the data you need.
Largest curated collection
The UW Drug Interaction Database (DIDB) has the largest manually curated collection of preclinical (in vitro, human) and clinical (in vivo) data available.
More data every day
00,000 citations with 000,000 entries
000 NDA/BLAs with 0,000 entries
Only from the most relevant publications and regulatory documents.
New FDA marker queries
These allow you to search for in vitro and clinical data for inhibitors of CYP markers, and, in a second step from the query results page, view clinical concentrations of each inhibitor.
Dedicated to supporting scientists in their decision-making process when evaluating pharmacokinetic (PK)-based drug interactions and drug safety.
Providing custom solutions
The Drug Interaction Solutions team can assist in leveraging the extensive in vitro and in vivo content of the DIDB to best suit your project-specific needs.
The preclinical datasets contain results from both human in vitro metabolism and transporter studies. These datasets have been trusted and used by pharmaceutical and regulatory scientists for 20 years.
The clinical datasets contain results from drug-drug, drug-food, drug-herb interaction, organ impairment, and pharmacogenetics studies.
Trusted by scientists
Internationally recognized and trusted
DIDB is internationally recognized as an authoritative, unbiased, transparent research tool by over 120 organizations from over 40 countries working in:
- Pharmaceutical companies of all sizes
- Regulatory agencies
- Contract Research Organizations
- Academics institutions
- Non-profit organizations
- Publishers of drug information
- Providers of clinical decision support system